ANDA 215984, held by Teva Pharms Inc. Valbenazine Tosylate.
As of Nov 16, 2026, ANDA 215984 (Valbenazine Tosylate), held by Teva Pharms Inc, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 21, 2026 | Original application | Tentative approval |
| Valbenazine Tosylate40MG · capsule;oral | Valbenazine Tosylate | None (tentative approval) |
| Valbenazine Tosylate80MG · capsule;oral | Valbenazine Tosylate | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters